Lupin Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is ILOPERIDONE, with a corresponding US DMF Number 27077.
Remarkably, this DMF maintains an Active status since its submission on June 14, 2013, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of June 05, 2014, and payment made on May 07, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II